This study investigates pancreatic adenocarcinoma. It involves collecting blood samples to evaluate circulating biomarkers.
The study focuses on understanding how these biomarkers can be used in the context of pancreatic cancer. It evaluates the relationship between biomarkers and the condition.
- Who can participate: Adults 18 years and older with a diagnosis of pancreatic adenocarcinoma who are patients at the University of Pennsylvania and can provide informed consent may participate.
- Study details: Participants will provide blood samples for the study. The study involves evaluating these samples for circulating biomarkers.